MVF (MVF) News
Follow MVF (MVF) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 19 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Jefferies cuts Monash IVF target to A$0.80
Jefferies cut its Monash IVF target price by 3.6% to A$0.80 per share (MVF.AU).
EQUITY | Sep 01, 2026, 01:21 AM UTC
L
Monash IVF target price raised 0.5% to A$0.75
Bell Potter raised Monash IVF’s target price by 0.5% to A$0.75 per share for MVF.AU.
EQUITY | Sep 01, 2026, 01:12 AM UTC
L
Morgans raises Monash IVF target price 2.5% to A$0.82
Morgans lifted its Monash IVF target price by 2.5% to A$0.82 per share.
EQUITY | Aug 31, 2026, 11:38 PM UTC
L
Monash IVF raised to accumulate by Morgans
Monash IVF was raised to accumulate from a spec buy by Morgans. The note is for MVF.AU.
EQUITY | Aug 31, 2026, 11:38 PM UTC
L
MVF: Resilient FY 2026 results with renewed momentum and a focus on growth and productivity in FY 2027
MVF: Resilient FY 2026 results with renewed momentum and a focus on growth and productivity in FY 2027
EARNINGS | Aug 31, 2026, 02:45 AM UTC
L
MVF flags lower FY 2026 earnings; FY 2027 growth, margin recovery expected
MVF says FY 2026 earnings are lower despite resilient revenue. It expects growth and margin recovery in FY 2027.
EARNINGS | Aug 31, 2026, 02:10 AM UTC
L
Monash IVF Group reports FY revenue of AUD 269.5 million
Monash IVF Group posted FY revenue of AUD 269.5 million.
EQUITY | Aug 31, 2026, 01:52 AM UTC
L
Monash IVF Group appoints Catherine West as chair-elect
Monash IVF Group has appointed Catherine West as chair-elect.
EQUITY | Aug 31, 2026, 01:34 AM UTC
M
MVF underlying NPAT drops 41% to $16.1m
MVF underlying NPAT fell 41% to $16.1m; revenue declined 1% and EBITDA fell 19%.
EQUITY | Aug 30, 2026, 10:40 PM UTC
L
MVF: FY26 saw resilient revenue, margin pressure, record international growth, and a positive FY27 outlook
MVF: FY26 saw resilient revenue, margin pressure, record international growth, and a positive FY27 outlook
EARNINGS | Aug 30, 2026, 10:40 PM UTC
L
Monash IVF expects financial performance to strengthen through FY27
Monash IVF expects financial performance to strengthen through FY27.
EQUITY | Aug 30, 2026, 10:25 PM UTC
L
Monash IVF: Focused on Sustainable Growth, Productivity, Stronger Returns>MVF.AU
Monash IVF: Focused on Sustainable Growth, Productivity, Stronger Returns>MVF.AU
EQUITY | Aug 30, 2026, 10:24 PM UTC
L
Monash IVF Says It Entered FY27 With Improved Momentum>MVF.AU
Monash IVF Says It Entered FY27 With Improved Momentum>MVF.AU
EQUITY | Aug 30, 2026, 10:24 PM UTC
L
Monash IVF declares dividend of A$0.013 per share
Monash IVF declares a dividend of A$0.013 per share for MVF.AU.
EQUITY | Aug 30, 2026, 10:23 PM UTC
M
MVF FY underlying net profit A$16.1M, down 41% y/y
Monash IVF reported FY underlying net profit of A$16.1M, down 41% year-on-year.
EQUITY | Aug 30, 2026, 10:23 PM UTC
L
Monash IVF FY EBIT A$20.2M vs MVF.AU
Monash IVF reports FY EBIT of A$20.2M for MVF.AU.
EARNINGS | Aug 30, 2026, 10:22 PM UTC
L
Monash IVF FY underlying EBITDA A$53.4M > MVF.AU
Monash IVF reported FY underlying EBITDA of A$53.4M for MVF.AU.
EQUITY | Aug 30, 2026, 10:22 PM UTC
L
Monash IVF reports FY revenue A$269.5M
Monash IVF FY revenue is A$269.5M for MVF.AU.
EQUITY | Aug 30, 2026, 10:22 PM UTC
M
Monash IVF FY net A$8.3M for MVF.AU
Monash IVF reported FY net profit of A$8.3M for MVF.AU.
EQUITY | Aug 30, 2026, 10:21 PM UTC